Delcath Systems Inc (DCTH) Stock Price

DCTHStock

$14.08+13.92%52W

Market Cap$488.56M

P/E180.95x

PEG Ratio1.60

Div yield—

Beta0.59

DCTH Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)19.51%

Price vs S&P 500 (4W)-11.28%

PEG Ratio1.60

VGM Score51.75

P/E Ratio (Annual)180.95x

P/CF (Annual)21.70x

Book Value / Share (Quarterly)$3.50

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)215.27%

Cash Flow / Share (Quarterly)$0.51

Price vs S&P 500 (YTD)27.48%

Gross Margin (TTM)87.05%

Net Profit Margin (TTM)0.56%

EPS (TTM)$0.01

10-Day Avg Trading Volume0.28M

EPS Excl Extra (TTM)$0.01

Revenue Growth (5Y)120.10%

EPS (Annual)$0.07

ROI (Annual)2.43%

Gross Margin (Annual)86.16%

Net Profit Margin (5Y Avg)-887.88%

Cash / Share (Quarterly)$2.77

P/E Basic Excl Extra (TTM)918.34x

Revenue Growth QoQ (YoY)20.60%

P/E Normalized (Annual)180.95x

ROA (Last FY)2.18%

Revenue Growth TTM (YoY)35.85%

EBITD / Share (TTM)$-0.04

ROE (5Y Avg)-132.44%

Operating Margin (TTM)-1.90%

Cash Flow / Share (Annual)$0.60

P/B Ratio4.03x

P/B Ratio (Quarterly)3.59x

Net Income / Employee (Annual)$17,300

EV / Revenue (TTM)4.62x

Net Interest Coverage (TTM)-32.13x

ROA (TTM)0.42%

EPS Growth QoQ (YoY)0.15%

EV / EBITDA (TTM)491.13x

EPS Incl Extra (Annual)$0.07

Current Ratio (Annual)10.92x

Quick Ratio (Quarterly)8.69x

3-Month Avg Trading Volume0.47M

52-Week Price Return13.92%

EV / Free Cash Flow (Annual)21.03x

P/E Incl Extra (TTM)918.34x

Revenue / Employee (TTM)$611,700

Tangible BV / Share (Quarterly)$1.26

P/S Ratio (Annual)5.73x

Asset Turnover (Annual)0.69x

52-Week High$17.42

Operating Margin (5Y Avg)-763.03%

EPS Excl Extra (Annual)$0.07

CapEx CAGR (5Y)14.68%

26-Week Price Return29.41%

Quick Ratio (Annual)9.69x

13-Week Price Return9.91%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)9.83x

Enterprise Value$441.04M

Revenue / Share Growth (5Y)30.28%

Asset Turnover (TTM)0.75x

Revenue / Employee (Annual)$546,400

Inventory Turnover (Annual)1.37x

Pretax Margin (Annual)4.12%

Cash / Share (Annual)$2.62

3-Month Return Std Dev60.80%

Gross Margin (5Y Avg)78.86%

Net Income / Employee (TTM)$3,400

ROE (Last FY)2.43%

Net Interest Coverage (Annual)-65.17x

EPS Basic Excl Extra (Annual)$0.07

P/FCF (TTM)27.91x

Receivables Turnover (TTM)6.01x

EV / Free Cash Flow (TTM)25.19x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$0.01

Receivables Turnover (Annual)7.53x

ROI (TTM)0.46%

P/S Ratio (TTM)5.12x

Pretax Margin (5Y Avg)-887.69%

Revenue / Share (Annual)$2.14

Tangible BV / Share (Annual)$-0.58

Price vs S&P 500 (52W)-1.62%

P/E Ratio (TTM)918.34x

EPS Growth TTM (YoY)-86.62%

Year-to-Date Return39.41%

5-Day Price Return-10.15%

EPS Normalized (Annual)$0.07

ROA (5Y Avg)-87.52%

Net Profit Margin (Annual)3.17%

Month-to-Date Return-11.83%

Cash Flow / Share (TTM)$-3.60

EBITD / Share (Annual)$0.02

Operating Margin (Annual)0.77%

LT Debt / Equity (Annual)0.00x

P/CF (TTM)24.94x

ROI (5Y Avg)-82.27%

P/E Excl Extra (TTM)918.34x

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$0.01

P/TBV (Quarterly)2.67x

P/B Ratio (Annual)3.21x

Inventory Turnover (TTM)1.11x

Pretax Margin (TTM)1.35%

Book Value / Share (Annual)$3.21

Price vs S&P 500 (13W)7.23%

Beta0.59x

P/FCF (Annual)23.30x

Revenue / Share (TTM)$2.40

ROE (TTM)0.46%

52-Week Low$8.12

vGradeD

gGradeC

mGradeB

vgmGradeC

DCTH Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 6, 2026	-$0.09	$0.07	+180.00%(+$0.16)
Q1 2026	May 7, 2026	-$0.09	-$0.03	+68.09%(+$0.06)
Q4 2025	Feb 26, 2026	-$0.03	-$0.05	-56.25%(-$0.02)
Q3 2025	Nov 4, 2025	-$0.09	$0.02	+122.22%(+$0.11)
Q2 2025	Aug 6, 2025	$0.03	$0.07	+169.23%(+$0.04)

DCTH Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.23

4.17

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24
RCELAvita Medical, Inc. Common Stock	D	C	A	5.3x	19.6%	82.1%	-46.6%	$13.04

About Delcath Systems Inc

Delcath Systems develops a drug-device combination for treating primary and metastatic liver cancers. Its proprietary Melphalan Hepatic Delivery System administers high-dose chemotherapy directly to the liver while minimizing systemic exposure and associated side effects. The company manufactures and distributes its products across the United States and Europe.

DCTH Next Earnings Report

Report dateNov 3, 2026

QuarterQ3 2026

Report timeBMO

EPS estimate-$0.07

Revenue estimate$25.84M

Also reporting on Nov 3, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

Companies in Related Industries

MLABMesa Laboratories IncIndustrial Instruments
CTKBCytek Biosciences, Inc. Common StockLab Analytical Instruments
AVRAnteris Technologies Global Corp. Common StockOrthopedic & Prosthetic Devices
PACBPacific Biosciences of California, Inc.Lab Analytical Instruments
MASS908 Devices Inc. Common StockLab Analytical Instruments
SENSSenseonics Holdings, Inc. Common StockIndustrial Instruments
FOSLFossil Group, Inc.Watches & Clocks
PREPrenetics Global Limited Class A Ordinary ShareLab Analytical Instruments

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.2

Buy

Consensus rating

52-Week Range

Low$8.12

High$17.42